Intra-Cellular Therapies Inc. buy Needham & Company LLC
Start price
05.04.24
/
50%
€64.00
Target price
05.04.25
€75.83
Performance (%)
5.47%
Price
29.04.24
€67.50
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL shows slight gains of 5.47%. This prediction currently runs until 05.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intra-Cellular Therapies Inc. | -3.571% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by Needham___Company_LL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $82.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Needham___Company_LL for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€84.46
22.04.25
22.04.25
-4.26%
29.04.24
29.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
23.02.24
23.02.24
€75.68
23.02.25
23.02.25
6.30%
29.04.24
29.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.70
03.08.23
03.08.23
€66.63
03.08.24
03.08.24
24.77%
29.04.24
29.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€60.85
29.03.24
29.03.24
22.14%
30.03.24
30.03.24